CG ONCOLOGY INC. - COMMON STOCK

22.37

25-April-25 16:45:00

15 minutes delayed

Stocks

+0.85

+3.95%

Today's range

21.00 - 22.37

ISIN

N/A

Source

NASDAQ

CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates

09 May 2024 08:00:00 By Nasdaq GlobeNewswire
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

03 May 2024 11:23:00 By Nasdaq GlobeNewswire
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

26 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

24 Apr 2024 10:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.